ESOMEPRAZOL IN TREATMENT OF GASTROESOPHAGIAL REFLUX DISEASE IN CHILDREN AND ADOLESCENTS
The results of trials of activity of esomeprazol in children with gastroesophagial reflux disease (gerd) are presented in this article. It was marked that esomeprazol (Nexium) can be used in children of 1–11 years (10 or 20 mg daily) and 12–17 years (20 or 40 mg daily) with gerd according to modern...
Yazar: | R.T. Saygitov |
---|---|
Materyal Türü: | Makale |
Dil: | English |
Baskı/Yayın Bilgisi: |
"Paediatrician" Publishers LLC
2008-08-01
|
Seri Bilgileri: | Вопросы современной педиатрии |
Online Erişim: | https://vsp.spr-journal.ru/jour/article/view/1441 |
Benzer Materyaller
-
ESOMEPRAZOL IN TREATMENT OF GASTROESOPHAGIAL REFLUX DISEASE IN CHILDREN AND ADOLESCENTS
Yazar:: R.T. Saygitov
Baskı/Yayın Bilgisi: (2008-01-01) -
Clinical utility of esomeprazole for treatment of gastroesophageal reflux disease in pediatric and adolescent patients
Yazar:: Cardile S, ve diğerleri
Baskı/Yayın Bilgisi: (2012-02-01) -
Efficacy of esomeprazole at treatment of patients with gastroesophageal reflux disease
Yazar:: Yu. V. Yevsyutina
Baskı/Yayın Bilgisi: (2018-08-01) -
Effects of esomeprazole treatment for gastroesophageal reflux disease on quality of life in 12- to 17-year-old adolescents: an international health outcomes study
Yazar:: Gold Benjamin D, ve diğerleri
Baskı/Yayın Bilgisi: (2009-11-01) -
Relationship between esomeprazole dose and timing to heartburn resolution in selected patients with gastroesophageal reflux disease
Yazar:: Roy C Orlando, ve diğerleri
Baskı/Yayın Bilgisi: (2010-09-01)